Tubulin inhibitor 6 (Compound 14b) is a novel and potent tubulin inhibitor (mitotic inhibitor or tubulin destabilizer) with anticancer activity.

Indibulin is a synthetic small molecule with antimitotic and potential antineoplastic activities.

Cevipabulin (formerly D-06576; TTI-237) is a triazolopyrimidine based microtubule targeting agent/tubulin inhibitor with potential antitumor activity.

Monomethyl auristatin F (MMAF) HCl is a highly potent tubulin inhibitor and an antineoplastic agent used as a warhead in ADCs (antibody-drug conjugates) such as vorsetuzumab mafodotin and SGN-CD19A.

ELR-510444 is a novel and potent inhibitor of microtubule polymeirzation (also called microtubule disruptor or mitotic inhibitor) with potential antivascular effects and in vivo antitumor efficacy, it can cause a loss of cellular microtubules and the formation of aberrant mitotic spindles which lead to mitotic arrest and apoptosis of cancer cells.

Vinblastine sulfate (also known as NSC49842; Vincaleukoblastine), a natural alkaloid extracted from the plant Vinca rosea Linn, is an approved anticancer drug and a potent mitotic inhibitor that inhibits microtubule formation and suppresses nAChR activity with IC50 of 8.9 μM in a cell-free assay, it is used to treat certain kinds of cancer.

Vinflunine ditartrate (F 12158, BMS 710485) is a new analog of the vinca alkaloid vinorelbine that is bi-fluorinated strucuturally.

PF-06380101 (Auristatin 0101; PF06380101; AUR-0101) is a novel and ultra-potent cytotoxic Dolastatin 10 analogue and a tubulin inhibitor with excellent anticancer activity.

Deoxypodophyllotoxin is a novel and potent analogue of podophyllotoxin

Vc-MMAD is composed of the ADC linker (Val-Cit) and MMAD which is a potent tubulin inhibitor.